Related references
Note: Only part of the references are listed.Dynamics of clonal evolution in myelodysplastic syndromes
Hideki Makishima et al.
NATURE GENETICS (2017)
Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium
A. M. Zeidan et al.
LEUKEMIA (2017)
Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation
R. C. Lindsley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Dynamic assessment of RBC-transfusion dependency improves the prognostic value of the revised-IPSS in MDS patients
Devendra K. Hiwase et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation
Tetsuichi Yoshizato et al.
BLOOD (2017)
Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes
D. A. Sallman et al.
LEUKEMIA (2016)
Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia
Klaus H. Metzeler et al.
BLOOD (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
TP53 mutation, mitochondria and cancer
William M. Kamp et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2016)
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias
Luana Fianchi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts
Luca Malcovati et al.
BLOOD (2015)
Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases
Chi Young Ok et al.
LEUKEMIA RESEARCH (2015)
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
R. Coleman Lindsley et al.
BLOOD (2015)
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
Terrence N. Wong et al.
NATURE (2015)
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R
Matteo G. Della Porta et al.
BLOOD (2014)
SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms
Emiliano Fabiani et al.
HAEMATOLOGICA (2014)
Application of the International Prognostic Scoring System-Revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemia
C. Y. Ok et al.
LEUKEMIA (2014)
Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms
F. Traina et al.
LEUKEMIA (2014)
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
T. Haferlach et al.
LEUKEMIA (2014)
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Giulio Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Elli Papaemmanuil et al.
BLOOD (2013)
Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia
Alan H. Shih et al.
HAEMATOLOGICA (2013)
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases
M. T. Voso et al.
LEUKEMIA (2013)
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes
M. J. Walter et al.
LEUKEMIA (2013)
Patients with therapy-related myelodysplastic syndromes and acute myeloid leukemia share genetic features but can be separated by blast counts and cytogenetic risk profiles into prognostically relevant subgroups
Ulrike Bacher et al.
LEUKEMIA & LYMPHOMA (2013)
Therapy-Related Myelodysplasia and Acute Myeloid Leukemia
Smita Bhatia
SEMINARS IN ONCOLOGY (2013)
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg et al.
BLOOD (2012)
The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML
Sabine Kayser et al.
BLOOD (2011)
Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
E. Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Genetics of therapy-related myelodysplasia and acute myeloid leukemia
J. Pedersen-Bjergaard et al.
LEUKEMIA (2008)
Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation
Philippe Armand et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Therapy-related myelodysplastic syndrome - Morphologic subclassification may not be clinically relevant
Zeba N. Singh et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML
C Schoch et al.
LEUKEMIA (2004)
Prognosis in therapy-related acute myeloid leukemia and impact of karyotype
W Kern et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series
SM Smith et al.
BLOOD (2003)
Share Paper
